SCHEMBL8459602

SCHEMBL8459602

CCC1CCN(N)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.36
SLC6A2 P23975 2/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRB3 P13945 1/20 0.36
ADRA2B P18089 1/20 0.36
DRD4 P21917 1/20 0.36
HTR2C P28335 1/20 0.36
HTR7 P34969 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
OPRK1 P41145 6/20 0.35
OPRM1 P35372 5/20 0.35
OPRL1 P41146 5/20 0.35
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13068179 0.82 SLC6A2 (0.38) HRH3SLC6A2HTR1AADRA2AADRB3
SCHEMBL24873325 0.81 KDM4C (0.46) HTR1AOPRK1OPRM1OPRL1KDM4C
SCHEMBL15731953 0.79 OPRM1 (0.35) HRH3SLC6A2HTR1AADRA2AADRB3
SCHEMBL18407453 0.74 NOTUM (0.53) HTR1AOPRK1DRD2
SCHEMBL709502 0.70 EEF2K (0.41) SLC6A2ADRA1ASLC6A3OPRM1SLC6A4
SCHEMBL8244093 0.69 CCKBR (0.44) HRH3SLC6A2HTR1AADRA2AADRB3
SCHEMBL13068132 0.69 PRKACA (0.33) HRH3SLC6A2HTR1AADRA2AADRA1A
SCHEMBL15818537 0.69 KDM4C (0.45) HTR2CMEN1USP2GAAKMT2A
SCHEMBL20244050 0.68 OPRM1 (0.38) OPRK1OPRM1OPRL1MEN1GAA
SCHEMBL18373678 0.68 SLC6A2 (0.38) HRH3SLC6A2HTR1AADRA2AADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918774-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1999-06-02 EP disclosed
WO-1997049709-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-12-31 WO disclosed